Latest Report - Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Latest Report - Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014

on

  • 90 views

Mild Cognitive Impairment Global Clinical Trials Review @ http://www.researchmoz.us/mild-cognitive-impairment-global-clinical-trials-review-h1-2014-report.html

Mild Cognitive Impairment Global Clinical Trials Review @ http://www.researchmoz.us/mild-cognitive-impairment-global-clinical-trials-review-h1-2014-report.html

Statistics

Views

Total Views
90
Views on SlideShare
90
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Latest Report - Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014 Document Transcript

  • 1. Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014 Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014" provides data on the Mild Cognitive Impairment clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mild Cognitive Impairment. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mild Cognitive Impairment. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 mild Cognitive Impairment 6 report Guidance 6 clinical Trials By Region 7 clinical Trials And Average Enrollment By Country 8 top Five Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 top Countries Contributing To Clinical Trials In Middle East And Africa 13 top Countries Contributing To Clinical Trials In Central And South America 14 clinical Trials By G7 Countries: Proportion Of Mild Cognitive Impairment To Central Nervous System Clinical Trials 15 clinical Trials By Phase In G7 Countries 16 clinical Trials In G7 Countries By Trial Status 17 clinical Trials By E7 Countries: Proportion Of Mild Cognitive Impairment To Central Nervous System Clinical Trials 18 clinical Trials By Phase In E7 Countries 19 clinical Trials In E7 Countries By Trial Status 20 clinical Trials By Phase 21 in Progress Trials By Phase 22 clinical Trials By Trial Status 23 clinical Trials By End Point Status 24 unaccomplished Trials Of Mild Cognitive Impairment 25 subjects Recruited Over A Period Of Time 29 clinical Trials By Sponsor Type 30 prominent Sponsors 31 top Companies Participating In Mild Cognitive Impairment Therapeutics Clinical Trials 32 prominent Drugs 34 clinical Trial Profiles 35 clinical Trial Overview Of Top Companies 35 pfizer Inc. 35 clinical Trial Overview Of Pfizer Inc. 35 novartis Ag 36 clinical Trial Overview Of Novartis Ag 36 johnson & Johnson 37 Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014
  • 2. clinical Trial Overview Of Johnson & Johnson 37 eisai Co., Ltd. 38 clinical Trial Overview Of Eisai Co., Ltd. 38 posit Science Corporation 39 clinical Trial Overview Of Posit Science Corporation 39 merck & Co., Inc. 40 clinical Trial Overview Of Merck & Co., Inc. 40 general Electric Company 41 clinical Trial Overview Of General Electric Company 41 dr. Willmar Schwabe Pharmaceuticals 42 clinical Trial Overview Of Dr. Willmar Schwabe Pharmaceuticals 42 chiesi Farmaceutici Spa 43 clinical Trial Overview Of Chiesi Farmaceutici Spa 43 clinical Trial Overview Of Top Institutes / Government 44 university Of Washington 44 clinical Trial Overview Of University Of Washington 44 u.s. Department Of Veterans Affairs 45 clinical Trial Overview Of U.s. Department Of Veterans Affairs 45 national Institute On Aging 46 clinical Trial Overview Of National Institute On Aging 46 university Hospital, Angers 47 clinical Trial Overview Of University Hospital, Angers 47 charite - Universitatsmedizin Berlin 48 clinical Trial Overview Of Charite - Universitatsmedizin Berlin 48 vanderbilt University 49 clinical Trial Overview Of Vanderbilt University 49 university Hospital Basel 50 clinical Trial Overview Of University Hospital Basel 50 national Institute Of Mental Health 51 clinical Trial Overview Of National Institute Of Mental Health 51 johns Hopkins University 52 clinical Trial Overview Of Johns Hopkins University 52 emory University 53 clinical Trial Overview Of Emory University 53 five Key Clinical Profiles 54 appendix 81 abbreviations 81 definitions 81 research Methodology 82 secondary Research 82 about Globaldata 83 contact Us 83 disclaimer 83 source 83 list Of Tables mild Cognitive Impairment Therapeutics, Global, Clinical Trials By Region, 2014* 7 mild Cognitive Impairment Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2014* 8 mild Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2014* 9 mild Cognitive Impairment Therapeutics Clinical Trials, Asia-pacific, Top Five Countries, 2014* 10 mild Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 mild Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 mild Cognitive Impairment Therapeutics Clinical Trials, Middle East And Africa, Top Countries, 2014* 13 mild Cognitive Impairment Therapeutics Clinical Trials, Central And South America, Top Countries, 2014* 14 proportion Of Mild Cognitive Impairment To Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 mild Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials By Phase, 2014* 16 mild Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2014* 17 proportion Of Mild Cognitive Impairment To Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 mild Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials By Phase, 2014* 19 mild Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2014* 20 mild Cognitive Impairment Therapeutics, Global, Clinical Trials By Phase, 2014* 21 mild Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress By Phase 2014* 22 mild Cognitive Impairment Therapeutics, Global, Clinical Trials By Trial Status, 2014* 23 mild Cognitive Impairment Therapeutics Clinical Trials, Global, By End Point Status, 2014* 24 mild Cognitive Impairment Therapeutics, Global, Suspended Clinical Trials, 2014* 25 mild Cognitive Impairment Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26 mild Cognitive Impairment Therapeutics, Global, Terminated Clinical Trials, 2014* 27 mild Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29 Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014
  • 3. mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials By Sponsor Type, 2014* 30 mild Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31 mild Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies By Phase, 2014* 33 mild Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2014* 34 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Pfizer Inc., 2014* 35 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Novartis Ag, 2014* 36 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Johnson & Johnson, 2014* 37 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Eisai Co., Ltd., 2014* 38 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Posit Science Corporation, 2014* 39 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Merck & Co., Inc., 2014* 40 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By General Electric Company, 2014* 41 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Dr. Willmar Schwabe Pharmaceuticals, 2014* 42 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Chiesi Farmaceutici Spa, 2014* 43 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of Washington, 2014* 44 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By U.s. Department Of Veterans Affairs, 2014* 45 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By National Institute On Aging, 2014* 46 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By University Hospital, Angers, 2014* 47 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Charite - Universitatsmedizin Berlin, 2014* 48 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Vanderbilt University, 2014* 49 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By University Hospital Basel, 2014* 50 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By National Institute Of Mental Health, 2014* 51 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Johns Hopkins University, 2014* 52 mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials By Emory University, 2014* 53 list Of Figures mild Cognitive Impairment Therapeutics, Global, Clinical Trials By Region (%), 2014* 7 mild Cognitive Impairment Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2014* 8 mild Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2014* 9 mild Cognitive Impairment Therapeutics Clinical Trials, Asia-pacific, Top Five Countries (%), 2014* 10 mild Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 mild Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 mild Cognitive Impairment Therapeutics Clinical Trials, Middle East And Africa, Top Countries (%), 2014* 13 mild Cognitive Impairment Therapeutics Clinical Trials, Central And South America, Top Countries (%), 2014* 14 proportion Of Mild Cognitive Impairment To Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 mild Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials By Phase, 2014* 16 mild Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2014* 17 proportion Of Mild Cognitive Impairment To Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 mild Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials By Phase, 2014* 19 mild Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2014* 20 mild Cognitive Impairment Therapeutics, Global, Clinical Trials By Phase (%), 2014* 21 mild Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress By Phase, 2014* 22 mild Cognitive Impairment Therapeutics, Global, Clinical Trials By Trial Status, 2014* 23 mild Cognitive Impairment Therapeutics Clinical Trials, Global, By End Point Status, 2014* 24 mild Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29 mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials By Sponsor Type (%), 2014* 30 mild Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31 mild Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies By Phase, 2014* 32 mild Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2014* 34 globaldata Methodology 82 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014